PubRank

J Mimuro

Author PubWeight™ 25.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 1989 1.49
2 Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. Blood 1987 1.20
3 Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost 2006 1.17
4 The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. J Cell Biol 1990 0.98
5 A thrombotic state due to an abnormal protein C. N Engl J Med 1988 0.94
6 Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin. Cell Differ Dev 1990 0.91
7 Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A. J Thromb Haemost 2004 0.86
8 Purpura fulminans in a Chinese boy with congenital protein C deficiency. Pediatrics 1986 0.85
9 Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin. Thromb Res 1984 0.83
10 Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency. Blood 1984 0.83
11 A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I. Blood 1996 0.81
12 Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A. J Thromb Haemost 2009 0.81
13 Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. J Clin Invest 1986 0.81
14 Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation. Blood 1999 0.80
15 Autoantibody against prothrombin aberrantly alters the proenzyme to facilitate formation of a complex with its physiological inhibitor antithrombin III without thrombin conversion. Blood 2001 0.79
16 Fibrinogen Niigata with impaired fibrin assembly: an inherited dysfibrinogen with a Bbeta Asn-160 to Ser substitution associated with extra glycosylation at Bbeta Asn-158. Blood 1999 0.79
17 Monocytes modulate the fibrinolytic balance of endothelial cells. Thromb Res 1997 0.79
18 Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy. Gene Ther 2004 0.79
19 Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice. Haemophilia 2011 0.79
20 Inhibitors of urokinase and thrombin in cultured neural cells. J Neurochem 1991 0.79
21 Expression of plasminogen activator inhibitor 2 in the adult and embryonic mouse tissues. Thromb Haemost 1996 0.78
22 End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extension lead to fragile clot structure. Blood 2000 0.78
23 Effect of staphylokinase concentration of plasminogen activation. Biochim Biophys Acta 1995 0.78
24 Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitor. Blood 1987 0.77
25 A classification of the fibrin network structures formed from the hereditary dysfibrinogens. J Thromb Haemost 2006 0.77
26 Fibrinolytic components in fetal membranes and amniotic fluid. Am J Obstet Gynecol 1993 0.76
27 Role of the kringle domain in plasminogen activation with staphylokinase. J Biochem 1998 0.76
28 Retinal pigment epithelial cells produce a latent fibrinolytic inhibitor that is antigenically and biochemically related to type 1 plasminogen activator inhibitor produced by vascular endothelial cells. Exp Eye Res 1989 0.75
29 Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice. J Thromb Haemost 2012 0.75
30 Production of functional coagulation factor VIII from iPSCs using a lentiviral vector. Haemophilia 2014 0.75
31 Clot lysis induced by a monoclonal antibody against alpha 2-plasmin inhibitor. Blood 1989 0.75
32 The plasminogen activator inhibitor-1 binding site in the kringle-2 domain of tissue-type plasminogen activator. Biochem Biophys Res Commun 1991 0.75
33 [Report of a family with hereditary angioneurotic edema (author's transl)]. Nihon Naika Gakkai Zasshi 1980 0.75
34 [Severe jaundice and hemophagocytic histiocytosis after autologous bone marrow transplantation in a patient with malignant lymphoma]. Rinsho Ketsueki 1987 0.75
35 [Type 1 plasminogen activator inhibitor]. Rinsho Byori 1990 0.75
36 A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen. J Biochem 1997 0.75
37 Effect of glycosidase inhibitors on the biosynthesis of alpha 2-plasmin inhibitor and antithrombin III in Hep G2 cells. Biochim Biophys Acta 1994 0.75
38 [Pathophysiology and treatment of thrombosis. (3) Protein C deficiency and thrombosis]. Nihon Naika Gakkai Zasshi 1987 0.75
39 [A case of idiopathic Fanconi syndrome without cystinosis (author's transl)]. Nihon Jinzo Gakkai Shi 1980 0.75
40 Morphological assessment of the luminal surface of olfactory epithelium in mice deficient in tissue plasminogen activator following bulbectomy. J Laryngol Otol 2012 0.75
41 Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1. J Biochem 1992 0.75
42 [Refractory bilateral pneumothoraces complicated with interstitial pneumonitis after bone marrow transplantation]. Rinsho Ketsueki 1993 0.75
43 [Determination of functional and antigen levels of protein C by a variation of enzyme-linked immunosorbent assay]. Nihon Ketsueki Gakkai Zasshi 1987 0.75
44 Fibrinolytic components in nasal mucosa and nasal secretion. Histochem Cell Biol 1998 0.75
45 [Analysis of alpha 2-plasmin inhibitor]. Rinsho Byori 1985 0.75
46 Level of protein C determined by combined assays during disseminated intravascular coagulation and oral anticoagulation. Blood 1987 0.75